Torthaí cuardaigh - Lais Durant

  • 1 - 2 toradh as 2 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    897P HORMONET: Phase II trial of tamoxifen for patients (pts) with estrogen/progesterone receptor (ER/PR)-positive neuroendocrine tumors (NET)

    897P HORMONET: Phase II trial of tamoxifen for patients (pts) with estrogen/progesterone receptor (ER/PR)-positive neuroendocrine tumors (NET) de réir R.S.P. Riechelmann, J. Strosberg, T. Al-Toubah, Lais Durant, M.D. Spina Donadio, Celso Abdon Lopes de Mello, V.H.F. De Jesus, T.C. Felismino, R.G. Taboada, L. De Brot Andrade, M. Barros

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors

    HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors de réir Milton Barros, Jonathan Strosberg, Taymeyah Al‐Toubah, Victor Hugo Fonseca de Jesus, Lais Durant, Celso Abdon Lopes de Mello, Tiago Cordeiro Felismino, L. De Brot, Rodrigo G. Taboada, Mauro Daniel Spina Donadio, Rachel P. Riechelmann

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: